Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer
Clinical trial NCT06719700 · RECRUITING
Trial details
- NCT number
- NCT06719700
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-30
- Primary completion
- 2028-11-29
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.